You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CLOPIDOGREL BISULFATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for clopidogrel bisulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00020189 ↗ Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Completed National Cancer Institute (NCI) Phase 2 2000-06-01 RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have recurrent or metastatic head and neck cancer.
NCT00263211 ↗ A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients Terminated Barnes-Jewish Hospital Phase 2 2006-01-01 The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer.
NCT00263211 ↗ A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients Terminated Washington University School of Medicine Phase 2 2006-01-01 The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer.
NCT00528411 ↗ A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin Completed AstraZeneca Phase 2 2007-10-01 The purpose of this study is to see how Ticagrelor, a new oral reversible anti-platelet medication, affects platelets. Anti-platelet agents are medications that block the formation of blood clots by preventing the clumping of platelets. Blood clots prevent us from bleeding, but when they form inside the arteries their formation is linked to a risk of medical problems such as heart attack and stroke. This study investigated how long it takes for Ticagrelor to begin working and how long it takes for it to stop working after the last dose of drug. Ticagrelor will be compared to clopidogrel, an established anti-platelet treatment for preventing blood clots, and placebo plus Aspirin.
NCT00648947 ↗ Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Completed Mylan Pharmaceuticals Phase 1 2004-12-01 The objective of this study was to investigate the bioequivalence of Mylan's clopidogrel bisulfate 75 mg tablets to Bristol-Myers Squibb/Sanofi's Plavix® 75 mg tablets following a single, oral 75 mg (1 x 75 mg) dose administered under fasting conditions.
NCT00650169 ↗ Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Completed Mylan Pharmaceuticals Phase 1 2004-12-01 The objective of this study was to investigate the bioequivalence of Mylan's clopidogrel bisulfate 75 mg tablets to Bristol-Myers Squibb/Sanofi's Plavix® 75 mg tablets following a single, oral 75 mg (1 x 75 mg) dose administered under fed conditions.
NCT00947843 ↗ Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents Completed CKD Pharmaceutical Limited Phase 4 2013-11-01 The purpose of this study is to compare the efficacy and tolerability between clopidogrel resinate and clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD equivalents.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for clopidogrel bisulfate

Condition Name

Condition Name for clopidogrel bisulfate
Intervention Trials
Healthy 5
Coronary Artery Disease 3
Breast Neoplasms 1
Stroke, Acute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for clopidogrel bisulfate
Intervention Trials
Myocardial Ischemia 5
Coronary Disease 5
Coronary Artery Disease 5
Ischemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for clopidogrel bisulfate

Trials by Country

Trials by Country for clopidogrel bisulfate
Location Trials
United States 11
India 4
Korea, Republic of 3
China 2
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for clopidogrel bisulfate
Location Trials
West Virginia 2
Maryland 2
Texas 1
South Dakota 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for clopidogrel bisulfate

Clinical Trial Phase

Clinical Trial Phase for clopidogrel bisulfate
Clinical Trial Phase Trials
Phase 4 6
Phase 2 3
Phase 1 8
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for clopidogrel bisulfate
Clinical Trial Phase Trials
Completed 15
Terminated 2
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for clopidogrel bisulfate

Sponsor Name

Sponsor Name for clopidogrel bisulfate
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
Torrent Pharmaceuticals Limited 2
Mylan Pharmaceuticals 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for clopidogrel bisulfate
Sponsor Trials
Other 15
Industry 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.